Beam

2 followers


Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.

Industries

Headquarters

Stage

Employees

Links

John Evans
Chief Executive Officer and Board Member

John Evans

Collapse
Brian Riley
Chief Manufacturing Officer
Christine Bellon
Chief Legal Officer
Manmohan Singh
Chief Technology Officer
Susan O’connor
Chief Human Resources Officer
Terry-Ann Burrell
Chief Financial Officer
John Lo
Chief Commercial Officer
Amy Simon
Chief Medical Officer
Gopi Shanker
Chief Scientific Officer